Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy

Lung cancer first line treatment has been directed from the non-specific cytotoxic doublet chemotherapy to the molecular targeted. The major limitation of the targeted therapies still remains the small number of patients positive to gene mutations. Furthermore, the differentiation between second lin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Domvri, Kalliopi, Zarogoulidis, Paul, Darwiche, Kaid, Browning, Robert F., Li, Qiang, Turner, J. Francis, Kioumis, Ioannis, Spyratos, Dionysios, Porpodis, Konstantinos, Papaiwannou, Antonis, Tsiouda, Theodora, Freitag, Lutz, Zarogoulidis, Konstantinos
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2013
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3842443/
https://ncbi.nlm.nih.gov/pubmed/24312144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.7734
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados